Accelerates protein design with machine learning and proprietary wet lab research
Life Sciences · Amsterdam · Founded 2021
What they build
Cradle is a biotechnology company that develops a platform for engineering proteins used in therapeutics and industrial applications. The company's core offering is a computational platform that combines machine learning models with high-throughput wet lab experimentation to accelerate the design and optimization of proteins. This integrated approach allows researchers to generate and test protein candidates with improved properties, such as enhanced binding affinity or thermal stability, in a fraction of the time compared to traditional methods. Cradle's platform is designed to guide the experimental process using proprietary data, enabling faster breakthroughs in areas like antibody and enzyme engineering. The company maintains its own wet lab facility to ensure the reliability and performance of its machine learning models before they are deployed to customers, offering a complete solution for protein discovery and optimization.
The people behind it
Who believes in them
Cradle raised €100M in total. The latest known round is Series B (2024).
Who works with them
What is being written
Where they are
Loading nearby…
Keep exploring